Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3635452013 | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | en | Definition | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 1479317011 | Tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3534602016 | Tablet (basic dose form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3865641000005115 | tablet | da | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Danish module (core metadata concept) |
| 4839601000005114 | tabletter | da | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Danish module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Is a | Type of drug preparation | false | Inferred relationship | Some | ||
| A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Is a | Oral dose form | false | Inferred relationship | Some | ||
| A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Is a | A dose form that displays properties of a solid. | true | Inferred relationship | Some | ||
| A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Has state of matter (attribute) | A state of matter where particles form a stable, definite shape that can only change by force (e.g. break, cut). | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| paroxetin 30 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| venlafaxin 37,5 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| venlafaxin 75 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| venlafaxin 50 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Nefazodone hydrochloride 100 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Nefazodone hydrochloride 200 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| nefazodonhydrochlorid 50 mg tablet + 100 mg + 200 mg, startpakning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Citalopram (as citalopram hydrobromide) 20 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Product containing precisely citalopram (as citalopram hydrobromide) 10 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Citalopram (as citalopram hydrobromide) 40 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| reboxetin 4 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Mirtazapine 30 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| dextroamphetaminsulfat 5 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| betahistinhydrochlorid 16 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| betahistinhydrochlorid 8 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Cinnarizine 15 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Cyclizine hydrochloride 50 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| domperidon 10 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Product containing precisely scopolamine hydrobromide 300 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Metoclopramide hydrochloride 10 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| metoclopramidhydrochlorid 15 mg tablet med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Metoclopramide hydrochloride 5 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Prochlorperazine maleate 5 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Prochlorperazine maleate 25 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Promethazine teoclate 25 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Cisapride 10 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Cisapride 20 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Ondansetron (as ondansetron hydrochloride) 4 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| ondansetron 8 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Product containing precisely granisetron (as granisetron hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Granisetron (as granisetron hydrochloride) 2 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Aspirin 300 mg gastro-resistant oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| acetylsalicylsyre 300 mg opløselig tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| acetylsalicylsyre 500 mg opløselig tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Paracetamol 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| paracetamol 500 mg opløselig tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Methionine 100 mg and paracetamol 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Methionine 250 mg and paracetamol 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Naproxen sodium 275 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Nefopam hydrochloride 30 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| co-codamol 8 mg + 500 mg dispergibel tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| acetylsalicylsyre 400 mg + codein 8 mg dispergibel tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| co-proxamol 32,5 mg + 325 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| aspirin 500 mg + papaveretum 7,71 mg dispergibel tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Codeine phosphate 30 mg and paracetamol 500 mg effervescent oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Dihydrocodeine tartrate 20 mg and paracetamol 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Dihydrocodeine tartrate 30 mg and paracetamol 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Product containing precisely codeine phosphate 13.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| paracetamol + diphenhydraminhydrochlorid 500 mg/25 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Codeine phosphate 12.8 mg and paracetamol 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Codeine phosphate 15 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Codeine phosphate 30 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Codeine phosphate 60 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Dextromoramide 5 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Dextromoramide 10 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Diamorphine hydrochloride 10 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| dihydrocodeintartrat 30 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| dihydrocodeintartrat 60 mg tablet med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| dihydrocodeintartrat 90 mg tablet med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| dihydrocodeintartrat 120 mg tablet med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| dihydrocodeintartrat 40 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| dipipanon 10 mg + cyclizin 30 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Methadone hydrochloride 5 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Pentazocine hydrochloride 25 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| pethidinhydrochlorid 50 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| tramadolhydrochlorid 100 mg tablet med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| tramadolhydrochlorid 150 mg tablet med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| tramadolhydrochlorid 200 mg tablet med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| tramadolhydrochlorid 50 mg opløselig tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| tramadolhydrochlorid 75 mg tablet med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| tramadolhydrochlorid 300 mg tablet med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| tramadolhydrochlorid 400 mg tablet med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| oxycodonhydrochlorid 10 mg tablet med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| oxycodonhydrochlorid 20 mg tablet med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| oxycodonhydrochlorid 40 mg tablet med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| oxycodonhydrochlorid 80 mg tablet med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Morphine sulfate 10 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Morphine sulfate 20 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| morphinsulfat 5 mg tablet ed modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| morphinsulfat 10 mg kapsel med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| morphinsulfat 15 mg tablet med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| morphinsulfat 30 mg tablet med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| morphinsulfat 60 mg tablet med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| morphinsulfat 100 mg tablet med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| morphinsulfat 200 mg tablet med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Morphine sulfate 50 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Product containing precisely domperidone (as domperidone maleate) 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| paracetamol 500 mg + metoclopramid 5 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Tolfenamic acid 200 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Product containing precisely clonidine hydrochloride 25 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Carbamazepine 100 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Carbamazepine 200 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Carbamazepine 400 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| carbamazepin 200 mg tablet med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| carbamazepin 400 mg tablet med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Carbamazepine 200 mg chewable tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some |
Start Previous Page 7 of 28 Next End
This concept is not in any reference sets
FHIR